Table 2.
Cumulative incidence of metabolic syndrome in all population and stratified by physical activity according the VEGFb categories.
| All population | Low VEGFb group | High VEGFb group | ||||
|---|---|---|---|---|---|---|
| N at risk | New cases | Incidence (%(CI%)) | Incidence (%(CI%)) | Incidence (%(CI%)) | p value* | |
| IDF | 908 | 181 | 19,9 (17.3–22.5) | 0,20,7 (18.1–23.3) | 0,17,6 (15.1–20.1) | 0.33 |
| ATP-III | 908 | 146 | 16,1 (13.7–18.5) | 0,17,76 (15.3–20.2) | 0,11,01 (9.0–13.0) | 0.01 |
| Low physical activity | ||||||
| IDF | 365 | 82 | 22,5 (18.2–26.8) | 21,6 (17.4–25.8) | 26,0 (21.5–30.5) | 0.2 |
| ATP-III | 365 | 64 | 17,5 (13.6–21.4) | 16,7 (12.9–20.5) | 20,8 (16.6–25.0) | 0.2 |
| Moderate physical activity | ||||||
| IDF | 322 | 65 | 20,2 (15.8–24.6) | 20,8 (16.4–25.2) | 18,4 (14.2–22.6) | 0.4 |
| ATP-III | 322 | 54 | 16,8 (12.7–20.9) | 19,6 (15.3–23.9) | 7,9 (7.4–8,3.4) | 0.01 |
| High physical activity | ||||||
| IDF | 221 | 73 | 15,4 (10.6–20.2) | 18,9 (13.7–24.1) | 8,2 (4.6–11.8) | 0.03 |
| ATP-III | 221 | 28 | 12,7 (8.3–17.1) | 16,9 (12.0–21.8) | 4,1 (1.5–6.7) | 0.004 |
*p value for the differences according to VEGFb categories measured by Chi-Square test.
CI confidence interval, VEGFb vascular endothelial growth factor b, IDF International Diabetes Federation, ATP-III National Cholesterol Education Program Adult Treatment Panel III.